Streetbeat News

Price Targets

PRTA

Prothena Corp (NASDAQ:PRTA) has received analyst ratings in the last quarter with 1 bullish and 3 somewhat bullish, totaling 4 ratings. The 12-month price targets for PRTA have an average of $100.25, a high of $129.00, and a low of $62.00. This average represents a 20.78% increase from the previous target of $83.00. Analysts use various methods to determine their ratings, which are opinions and can vary in accuracy.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:00 pm

CSIQ

Canadian Solar (NASDAQ:CSIQ) received mixed analyst ratings in the last quarter with 1 bullish, 1 somewhat bullish, 3 indifferent, and 1 somewhat bearish rating. The average 12-month price target for CSIQ is $32.00, which is a 25.93% decrease from the previous target of $43.20. Analysts derive their ratings by evaluating company financials, attending calls and meetings, and communicating with insiders. Ratings are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:00 pm

BIDU

Benchmark analyst Fawne Jiang has reiterated a Buy rating on Baidu (NASDAQ:BIDU) and maintained a $210 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:59 pm

PRTA

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $129.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:57 pm

PTCT

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on PTC Therapeutics (NASDAQ:PTCT) and maintained a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:46 pm

TSHA

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Taysha Gene Therapies (NASDAQ:TSHA) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:44 pm

DRI

BMO Capital analyst Andrew Strelzik has maintained a 'Market Perform' rating on Darden Restaurants (NYSE:DRI) and increased the price target from $155 to $160.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:32 pm

GHRS

Stifel analyst Paul Matteis has maintained a Buy rating on GH Research (NASDAQ:GHRS) but has reduced the price target from $25 to $18.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:31 pm

MU

BMO Capital analyst Ambrish Srivastava has maintained an Outperform rating on Micron Technology (NASDAQ:MU) and increased the price target from $80 to $90.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:30 pm

XEL

BMO Capital analyst James Thalacker has maintained a 'Market Perform' rating on Xcel Energy (NASDAQ:XEL) and increased the price target from $59 to $62.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:28 pm